AUL
PRAX icon

AlphaGrep UK Ltd’s Praxis Precision Medicines PRAX Stock Holding History

AlphaGrep UK Ltd’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$365K Buy
+1,134
New +$351K 0.11% 417

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

AlphaGrep UK Ltd's PRAX Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in Praxis Precision Medicines (PRAX) in Q1 2026: 1,134 shares worth $365K. The stake represents 0.11% of the portfolio and ranks #417 among its holdings.

290 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • AlphaGrep UK Ltd held 1,134 shares of Praxis Precision Medicines worth $365K as of Q1 2026.
  • Praxis Precision Medicines was a new AlphaGrep UK Ltd position in Q1 2026.
  • Praxis Precision Medicines made up 0.11% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #417 holding.
  • 290 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.